ADDPI 2023_145 INADA vs Malak Singh

In June 2023 the India National Anti-Doping Agency (INADA) reported an anti-doping rule violation against the rower Malak Singh after his sample tested positive for the prohibited substances Mephentermine and Phentermine.

Following notification a provisional suspension was ordered and the Athlete was heard for the Anti-Doping Disciplinary Panel of India (ADDPI). The Athlete denied the intentional use of the substance and could not explain how the substances had entered into his system.

The Panel finds that the presence of the prohibited substances has been established in the Athlete's sample and accordingly that he had committed an anti-doping rule violation. The Panel deems that he failed to demonstrate how these substances had entered his system.

Therefore the ADDPI decides on 11 January 2024 to impose a 4 year period of inelgibility on the Athlete, starting on the date of the provisional suspension, i.e. 27 June 2023.

Original document

Parameters

Legal Source
National Decisions
Date
11 January 2024
Arbitrator
Shinde, Archana
Soodan, Sanjogita
Zongluju, Jyoti
Original Source
India National Anti-Doping Agency (INADA)
Country
India
Language
English
ADRV
Adverse Analytical Finding / presence
Sport/IFs
Rowing (WR) - World Rowing
Other organisations
Anti-Doping Disciplinary Panel of India (ADDPI)
India National Anti-Doping Agency (INADA)
Laboratories
New Delhi, India: National Dope Testing Laboratory
Doping classes
S6. Stimulants
Substances
Mephentermine
Phentermine
Document type
Pdf file
Date generated
19 February 2024
Date of last modification
21 March 2024
Category
  • Legal Source
  • Education
  • Science
  • Statistics
  • History
Country & language
  • Country
  • Language
Other filters
  • ADRV
  • Legal Terms
  • Sport/IFs
  • Other organisations
  • Laboratories
  • Analytical aspects
  • Doping classes
  • Substances
  • Medical terms
  • Various
  • Version
  • Document category
  • Document type
Publication period
Origin